Evidence mapPaperPMID 41597169Full record

ArticleCells2026

Mesenchymal Stem Cell-Derived Extracellular Vesicles Attenuate Pro-Inflammatory Macrophage Polarization: Comparison of Matrix-Bound and Small Extracellular Vesicles.

Timofey O Klyucherev, Maria D Yurkanova, Daria P Revokatova, Dmitriy A Chevalier, Vsevolod V Shishkov, Irina I Vlasova, Nastasia V Kosheleva, Peter S Timashev

Abstract readComparative Study
In one paragraph

Article in Cells, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Timofey O KlyucherevInstitute for Regenerative Medicine, I. M. Sechenov First Moscow State Medical University (Sechenov University), 119991 Moscow, Russia.
Maria D YurkanovaInstitute for Regenerative Medicine, I. M. Sechenov First Moscow State Medical University (Sechenov University), 119991 Moscow, Russia.ORCID 0009-0000-5591-9987
Daria P RevokatovaInstitute for Regenerative Medicine, I. M. Sechenov First Moscow State Medical University (Sechenov University), 119991 Moscow, Russia.
Dmitriy A ChevalierInstitute for Regenerative Medicine, I. M. Sechenov First Moscow State Medical University (Sechenov University), 119991 Moscow, Russia.
Vsevolod V ShishkovInstitute for Regenerative Medicine, I. M. Sechenov First Moscow State Medical University (Sechenov University), 119991 Moscow, Russia.
Irina I VlasovaInstitute for Regenerative Medicine, I. M. Sechenov First Moscow State Medical University (Sechenov University), 119991 Moscow, Russia.
Nastasia V KoshelevaInstitute for Regenerative Medicine, I. M. Sechenov First Moscow State Medical University (Sechenov University), 119991 Moscow, Russia.ORCID 0000-0002-2665-4972
Peter S TimashevInstitute for Regenerative Medicine, I. M. Sechenov First Moscow State Medical University (Sechenov University), 119991 Moscow, Russia.

Funding

Ministry of Science and Higher Education of the Russian Federation 075-15-2024-640
6 · The paper itself

Abstract

Macrophages play a crucial role in regulating immune responses, inflammation, and tissue repair. Depending on environmental cues, they polarize into pro-inflammatory M1 or anti-inflammatory, pro-regenerative M2 phenotypes. Extracellular vesicles (EVs) derived from mesenchymal stem/stromal cells (MSCs) have emerged as key mediators of intercellular communication and immune modulation. This study investigates the effects of matrix-bound vesicles (MBVs) and small extracellular vesicles (sEVs) derived from human umbilical cord MSCs (UC-MSCs) on human monocyte-derived macrophages (MDMs) in vitro. Both MBVs and sEVs reduced pro-inflammatory activation of M1 macrophages, downregulating the expression of CXCL10 and CD86 while increasing the M2 marker CD206. MBVs exerted a stronger suppressive effect on M1 MDM phenotype markers as well as on STAT1, STAT2, and IRF9 mRNA levels in M1 macrophages, indicating the inhibition of the JAK/STAT1 signaling pathway involved in the pro-inflammatory activation of macrophages. Functionally, both vesicle types enhanced phagocytosis of FITC-labeled

Indexed as

Cell PolarityExtracellular MatrixExtracellular VesiclesInflammationMacrophagesMesenchymal Stem CellsHumansMacrophage ActivationPhagocytosisReactive Oxygen SpeciesSignal TransductionReactive Oxygen Speciesmatrix-bound nanovesiclesmesenchymal stromal cellsmonocyte-derived macrophagesphagocytosissmall extracellular vesicles

Identifiers

PMID41597169
PMCPMC12838643

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.